Potential Linkage Between Cerebrovascular Diseases and Metabolic Syndrome

Nasimudeen R Jabir, Chelapram Kandy Firoz, Mohd Shahnawaz Khan

  • 1King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.

Current Drug Metabolism
|August 13, 2016
PubMed

Insights

Cerebrovascular disease (CD) and metabolic syndrome (MetS) share common pathological pathways, including insulin resistance and hypertension. Targeting these shared mechanisms with novel drugs may offer effective treatment strategies for both conditions.

Area of Science:

  • Cardiovascular Science
  • Metabolic Disorders
  • Neurology

Background:

  • Cerebrovascular disease (CD) and metabolic syndrome (MetS) are significant global health issues contributing to mortality and disability.
  • These conditions often co-exist and share mechanistic similarities, exacerbating pathological processes.
  • Modifiable risk factors present in both CD and MetS highlight the potential for therapeutic intervention.

Purpose of the Study:

  • To summarize common pathological conditions linking CD and MetS.
  • To advocate for the development of common treatment strategies targeting shared molecular pathways.
  • To explore the potential of multi-targeted drug discovery for managing these interconnected diseases.

Main Methods:

  • Review and synthesis of existing scientific data on the mechanistic links between CD and MetS.
  • Identification of shared pathological conditions such as abdominal obesity, insulin resistance, dyslipidemia, hypertension, and endothelial dysfunction.
  • Analysis of therapeutic implications of targeting common pathways.

Main Results:

  • Abdominal obesity, insulin resistance, dyslipidemia, hypertension, and endothelial dysfunction are identified as key common pathological conditions.
  • These shared factors significantly worsen the homeostasis in individuals with CD and MetS.
  • The co-existence of CD and MetS amplifies the risk of severe health events.

Conclusions:

  • Developing common treatment strategies for CD and MetS is a promising therapeutic avenue.
  • Common molecular agents targeting shared pathways could be effective.
  • Advancement in novel multi-targeted drug discovery is crucial for preventing fatal complications of CD and MetS.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.2K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
653
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
879
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K